Action AXDX ACCELERATE DIAGNOSTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Accelerate Diagnostics, Inc.

Actions

AXDX

US00430H2013

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 25/04/2024 		Varia. 5j. Varia. 1 janv.
0,9453 USD +1,54 % Graphique intraday de Accelerate Diagnostics, Inc. +22,77 % -75,89 %
29/03 Accelerate Diagnostics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
28/03 Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Accelerate Diagnostics, Inc. announced that it expects to receive $4.749996 million in funding from Jack W. Schuler Living Trust
Top Midday Decliners
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
Sector Update: Health Care Stocks Weaker Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Accelerate Diagnostics Announces Launch of Proposed Public Offering
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
Accelerate Diagnostics, Inc. Announces Preliminary Unaudited Revenue Results for the Year Ended December 31, 2023
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination with Bruker's MALDI Biotyper
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AXDX
  4. Actualités Accelerate Diagnostics, Inc.
  5. Autres langues